Clinical Trial Update: Dose Escalation Study of Liposomal Paclitaxel Plus Capecitabine in Chinese Patients With Advanced Gastric Carcinoma [Phase 1]

View source ↗

Summary

Phase 1 dose-escalation study of liposomal paclitaxel plus capecitabine in Chinese patients with advanced gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• liposomal paclitaxel (liposomal paclitaxel)

Snippet

Sponsor: Nanjing Sike Pharmaceutical Co., Ltd. | Conditions: Advanced Gastric Carcinoma | Phase 1 | Status: UNKNOWN